Patent details

Basic Information

Publication number:

EP3573960

PCT Application Number:

EP2018052172

Type:

European Patent Granted for LU

Legal Status:

Unitary Effect Registered

Application number:

EP187017595

PCT Publication Number:

WO2018138362

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

N-{[2-(PIPERIDIN-1-YL)PHENYL](PHENYL)METHYL}-2-(3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-7-YL)ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ROR-GAMMA MODULATORS FOR TREATING AUTOIMMUNE DISEASES

French Title of Invention:

DÉRIVÉS DE N-{[2-(PIPÉRIDIN-1-YL)PHÉNYL](PHÉNYL)MÉTHYL}-2-(3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-7-YL)ACÉTAMIDE ET COMPOSÉS SIMILAIRES EN TANT QUE MODULATEURS ROR-GAMMA POUR LE TRAITEMENT DE MALADIES D'AUTO-IMMUNITÉ

German Title of Invention:

N-{[2-(PIPERIDIN-1-YL)PHENYL](PHENYL)METHYL}-2-(3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-7-YL)ACETAMID-DERIVATE UND VERWANDTE VERBINDUNGEN ALS ROR-GAMMA MODULATOREN ZUR BEHANDLUNG VON AUTOIMMUNERKRANKUNGEN

SPC Number:

Unitary Effect

Unitary Effect Requested:

Yes

Unitary Effect Request Filing Date:

12/09/2023

Link to UPP Register:

European Patent Register

Unitary Effect Request Withdrawal Date:

Unitary Effect Status:

Unitary Effect Registered

Unitary Effect Acceptance Decision Date:

18/09/2023

Unitary Effect Rejection Decision Date:

Unitary Effect Date:

16/08/2023

Unitary Effect Registration Date:

18/09/2023

Unitary Effect Re-establishment of rights Filing Date:

Unitary Effect Re-establishment of rights EPO Decision :

Unitary Effect Re-establishment of rights EPO Decision Date:

Explanatory Text UE:

Safety Net Request Date:

Safety Net Decision Date:

Safety Net Decision Outcome:

SPC Number:

Dates

Filing date:

29/01/2018

Grant date:

16/08/2023

EP Publication Date:

04/12/2019

PCT Publication Date:

02/08/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/08/2023

EP B1 Publication Date:

16/08/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

29/01/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/08/2023

 

 

Name:

Genfit

Address:

885, Avenue Eugène Avinée, 59120 Loos, France (FR)

Inventor

1

Name:

MAJD, Zouher

Address:

France (FR)

2

Name:

DELHOMEL, Jean-François

Address:

France (FR)

3

Name:

PARROCHE, Peggy

Address:

France (FR)

4

Name:

WALCZAK, Robert

Address:

France (FR)

5

Name:

PERSPICACE, Enrico

Address:

France (FR)

Priority

1

Priority Number:

17305093

Priority Date:

27/01/2017

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

17178888

Priority Date:

29/06/2017

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

C07D 265/36; C07D 215/48; C07D 241/52; C07D 209/34; C07D 209/38; C07D 231/56; C07D 405/12; C07D 413/12; C07D 417/12; A61K 31/536; A61K 31/4725; A61K 31/498; A61K 31/454; A61K 31/425; A61P 37/00; A61P 37/06; A61P 37/08; A61P 31/00; A61P 19/02; A61P 11/06; A61P 1/04; A61P 1/16; A61P 3/00; A61P 3/10; A61P 9/00; A61P 9/10; A61P 11/00; A61P 13/12; A61P 17/00; A61P 17/06;

Publication

European Patent Bulletin

1

Issue number:

202333

Publication date:

16/08/2023

Description:

Grant (B1)

2

Issue number:

202342

Publication date:

18/10/2023

Description:

Unitary Effect Request Receipt

3

Issue number:

202342

Publication date:

18/10/2023

Description:

Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages